October 2015

New Product - Caldolor

Caldolor (ibuprofen) is indicated in adults for the management of acute mild to moderate postoperative pain and moderate to severe postoperative pain with adjunctive reduced morphine dosage, where an intravenous route of administration is considered clinically necessary. Caldolor is also indicated for the reduction of fever in adults where an intravenous route of administration is considered clinically necessary. It is contraindicated in patients who have experienced asthma, urticaria, or allergic type reactions after taking aspirin or other NSAIDs (severe, rarely fatal anaphylactic‑like reactions to NSAIDs have been reported in such patients); for the treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery; patients with active gastrointestinal bleeding; and in patients with spinal cord injuries. Caldolor is available as an 800 mg/ 8 mL concentrated injection in a carton of 10 vials.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au